← World Watch
Disruptionother · October 5, 2026
FDA approves additional U.S. manufacturing capacity for SIMLANDI, Alvotech's biosimilar to Humira
Additional U.S. manufacturing capacity for the SIMLANDI biosimilar should expand supply of adalimumab treatment.
Source →The trace
How it reaches your house.
Starting from Hybio Pharmaceutical Co., Ltd, we walked the supply graph hop by hop to the goods you buy and the companies you own. Each step is the engine’s reasoning, scored for confidence and cited where a source backs it.
The causal trace for this event is still being written.